US govt awards US$1.4b for development of new Covid-19 therapies, vaccines
Sign up now: Get ST's newsletters delivered to your inbox
The funding includes US$1 billion for four mid-stage clinical trials of new Covid-19 vaccines.
PHOTO: REUTERS
Follow topic:
WASHINGTON - The US government said on Tuesday it had awarded US$1.4 billion (S$1.9 billion) for the development of new therapies and vaccines against Covid-19, including a US$326 million contract with Regeneron Pharmaceuticals for a next-generation antibody therapy for prevention of infections.
The funding to Regeneron is a part of a US$5 billion initiative dubbed “Project NextGen” by the US Department of Health and Human Services (HHS).
Regeneron had earlier developed a monoclonal antibody therapy against Covid-19,
The funding also includes US$1 billion for four mid-stage clinical trials of new Covid-19 vaccines, and US$100 million to Global Health Investment Corp - a non-profit organisation that invests in new technologies that will accelerate responses to diseases. REUTERS
